Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
43
PharmaCompass offers a list of Adagrasib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Adagrasib manufacturer or Adagrasib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Adagrasib manufacturer or Adagrasib supplier.
PharmaCompass also assists you with knowing the Adagrasib API Price utilized in the formulation of products. Adagrasib API Price is not always fixed or binding as the Adagrasib Price is obtained through a variety of data sources. The Adagrasib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Adagrasib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Adagrasib, including repackagers and relabelers. The FDA regulates Adagrasib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Adagrasib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Adagrasib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Adagrasib supplier is an individual or a company that provides Adagrasib active pharmaceutical ingredient (API) or Adagrasib finished formulations upon request. The Adagrasib suppliers may include Adagrasib API manufacturers, exporters, distributors and traders.
click here to find a list of Adagrasib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Adagrasib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Adagrasib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Adagrasib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Adagrasib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Adagrasib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Adagrasib suppliers with NDC on PharmaCompass.
Adagrasib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Adagrasib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Adagrasib GMP manufacturer or Adagrasib GMP API supplier for your needs.
A Adagrasib CoA (Certificate of Analysis) is a formal document that attests to Adagrasib's compliance with Adagrasib specifications and serves as a tool for batch-level quality control.
Adagrasib CoA mostly includes findings from lab analyses of a specific batch. For each Adagrasib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Adagrasib may be tested according to a variety of international standards, such as European Pharmacopoeia (Adagrasib EP), Adagrasib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Adagrasib USP).
